Recro Pharma: FDA Grants Appeal For IV Meloxicam, Adding Value To The Proposed Acute Care Spin-Out [Seeking Alpha]
Recro Pharma, Inc. (REPH)
Last recro pharma, inc. earnings: 11/8 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.recropharma.com
Company Research
Source: Seeking Alpha
Recro Pharma: FDA Grants Appeal For IV Meloxicam, Adding Value To The Proposed Acute Care Spin-Out Recro Pharma ( REPH The appeal news is announced only a couple of days after the company submitted an SEC filing Figure 1: REPH Daily Chart (Source: Trendspider) I intend to review IV Meloxicam and the company's plan to spin-out their Acute Care Segment into a separate publicly-traded company. In addition, I take a look at the company's current valuation and defend a speculative buy at these current prices. About IV Meloxicam Meloxicam is a COX-2 inhibitor that has analgesic, antipyretic, and even anti-inflammatory abilities. Recro has created an IV formulation of Meloxicam ALKS NanoCrystal technology Despite the growing need for non-opioid alternatives in the Acute Care setting, the FDA has not been friendly with Recro and IV Meloxicam. The IV Meloxicam product was issued its first CRL resubmitted PDUFA date second CRL mentioned publicized DAAAP Following the second CRL, I was concerned
Show less
Read more
Impact Snapshot
Event Time:
REPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
REPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
REPH alerts
High impacting Recro Pharma, Inc. news events
Weekly update
A roundup of the hottest topics